Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:BUS NYSE:CRL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBUSGrande West Transportation GroupC$2.42-2.4%C$2.42C$0.24▼C$4.59C$70.88MN/A800,426 shs430,368 shsCRLCharles River Laboratories International$177.96-2.0%$170.79$132.58▼$228.88$8.76B1.44805,437 shs978,093 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBUSGrande West Transportation Group0.00%0.00%0.00%0.00%0.00%CRLCharles River Laboratories International-2.20%+7.26%+1.20%-5.90%+30.44%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBUSGrande West Transportation GroupC$2.42-2.4%C$2.42C$0.24▼C$4.59C$70.88MN/A800,426 shs430,368 shsCRLCharles River Laboratories International$177.96-2.0%$170.79$132.58▼$228.88$8.76B1.44805,437 shs978,093 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBUSGrande West Transportation Group0.00%0.00%0.00%0.00%0.00%CRLCharles River Laboratories International-2.20%+7.26%+1.20%-5.90%+30.44%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBUSGrande West Transportation Group 0.00N/AN/AN/ACRLCharles River Laboratories International 2.63Moderate Buy$205.8615.68% UpsideCurrent Analyst Ratings BreakdownLatest CRL, SCE, SWL, and BUS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2026CRLCharles River Laboratories International Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$213.005/8/2026CRLCharles River Laboratories International EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$220.005/8/2026CRLCharles River Laboratories International MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$192.005/8/2026CRLCharles River Laboratories International BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$210.00 ➝ $220.004/20/2026CRLCharles River Laboratories International Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)4/14/2026CRLCharles River Laboratories International BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$200.00 ➝ $210.004/14/2026CRLCharles River Laboratories International Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$215.004/14/2026CRLCharles River Laboratories International Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageModerate Buy$215.004/13/2026CRLCharles River Laboratories International JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$165.00 ➝ $160.004/8/2026CRLCharles River Laboratories International EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform(Data available from 5/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBUSGrande West Transportation GroupC$27.02M2.62C$0.01 per share165.33C$0.18 per share13.37CRLCharles River Laboratories International$4.02B2.19$22.00 per share8.09$59.71 per share2.98Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBUSGrande West Transportation GroupN/A-C$0.08N/AN/AN/AN/AN/AN/AN/ACRLCharles River Laboratories International-$144.34M-$3.76N/A14.762.15-4.59%15.36%6.61%N/ALatest CRL, SCE, SWL, and BUS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026CRLCharles River Laboratories International$1.96$2.06+$0.10-$0.30$977.46 million$995.83 million2/18/2026Q4 2025CRLCharles River Laboratories International$2.33$2.39+$0.06-$5.62$986.98 million$994.23 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBUSGrande West Transportation GroupN/AN/AN/AN/AN/ACRLCharles River Laboratories InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBUSGrande West Transportation Group55.321.590.38CRLCharles River Laboratories International0.901.361.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBUSGrande West Transportation GroupN/ACRLCharles River Laboratories International98.91%Insider OwnershipCompanyInsider OwnershipBUSGrande West Transportation GroupN/ACRLCharles River Laboratories International1.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBUSGrande West Transportation GroupN/A29.29 millionN/ANot OptionableCRLCharles River Laboratories International19,70049.34 million48.70 millionOptionableCRL, SCE, SWL, and BUS HeadlinesRecent News About These CompaniesIs It Time To Rethink Charles River Laboratories (CRL) After Its Recent Price Rebound?May 9 at 12:02 AM | finance.yahoo.comCharles River Laboratories International Q1 Earnings Call HighlightsMay 9 at 7:02 PM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Issues Earnings ResultsMay 9 at 5:29 PM | marketbeat.comComerica Bank Has $1.24 Million Stake in Charles River Laboratories International, Inc. $CRLMay 9 at 3:53 AM | marketbeat.comLH vs. CRL: Which Stock Is the Better Value Option?May 8 at 12:41 PM | zacks.comCharles River Laboratories International, Inc. (NYSE:CRL) Q1 2026 Earnings Call TranscriptMay 8 at 9:10 AM | insidermonkey.comCRL Q1 deep dive: Portfolio restructuring and cost initiatives set stage for margin expansionMay 8 at 7:20 AM | msn.comCharles River Laboratories International, Inc. (CRL) Q1 2026 Earnings Call TranscriptMay 7 at 4:02 PM | seekingalpha.comCharles River Q1 Review: Near-Term Stability But Long-Term Risks (Downgrade)May 7 at 1:03 PM | seekingalpha.comCRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock DownMay 7 at 11:20 AM | zacks.comCompared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key MetricsMay 7 at 10:31 AM | zacks.comCharles River Laboratories (CRL) Surpasses Q1 Earnings and Revenue EstimatesMay 7 at 9:56 AM | zacks.comCharles River Laboratories International, Inc. 2026 Q1 - Results - Earnings Call PresentationMay 7 at 9:04 AM | seekingalpha.comCharles River Laboratories International (NYSE:CRL) Updates FY 2026 Earnings GuidanceMay 7 at 8:44 AM | marketbeat.comCharles River Associates (CRA) Reports Financial Results for the First Quarter of 2026May 7 at 8:05 AM | businesswire.comCharles River beats quarterly estimates on steady demand for drug development servicesMay 7 at 7:54 AM | reuters.comCharles River (CRL) Q1 Earnings Preview: What You Should Know Beyond the Headline EstimatesMay 6, 2026 | zacks.comCharles River Laboratories (CRL) to report earnings tomorrow: Here is what to expectMay 6, 2026 | msn.comVan Berkom & Associates Inc. Sells 46,221 Shares of Charles River Laboratories International, Inc. $CRLMay 5, 2026 | marketbeat.comDanske Bank A S Increases Stake in Charles River Laboratories International, Inc. $CRLMay 5, 2026 | marketbeat.comCharles River Gears Up for Q1 Earnings: What's in the Cards?May 4, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThese are the 3 Biggest AI Winners and Losers of 2026By Leo Miller | April 13, 2026Palantir Is Down 30%: Noise? Or a Signal to Accumulate?By Chris Markoch | April 28, 2026Up Over 200% in 2026, What's Next for AI Stock Aehr Test Systems?By Leo Miller | April 10, 2026Monolithic Power Systems: AI Stock Beat, Raised and Upgraded Post-EarningsBy Leo Miller | May 5, 20265 Stocks Leading the Market's Rebound: The AI Connectivity TradeBy Ryan Hasson | April 13, 2026CRL, SCE, SWL, and BUS Company DescriptionsGrande West Transportation Group CVE:BUSC$2.42 -0.06 (-2.42%) As of 03/26/2021Grande West Transportation Group Inc. designs, engineers, manufactures, and sells Vicinity branded mid-size multi-purpose transit vehicles for public and commercial enterprises in the United States and Canada. It offers buses in clean diesel, gas, and CNG drive systems; and also produces and sells spare parts. The company was founded in 2008 and is headquartered in Aldergrove, Canada.Charles River Laboratories International NYSE:CRL$177.96 -3.72 (-2.05%) Closing price 05/8/2026 03:59 PM EasternExtended Trading$177.60 -0.35 (-0.20%) As of 05/8/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/04 - 05/08 Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance 3 Under-The-Radar Small Caps Making New All-Time Highs Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
